Engagement summary
Client Background
Arcadia Biosciences is a publicly traded agricultural biotechnology company focused on crop improvements that enhance farm economics and reduce environmental impact.
Engagement Scope
R&M has served as Arcadia's outsourced SOX 404 and SEC technical-accounting team since 2016, supporting every quarterly 10-Q and annual 10-K filing, ASC 606 revenue recognition, and ongoing SOX 404 testing across multiple fiscal years.
Services Provided
- SOX 404 compliance and control testing
- 10-K annual filing preparation
- 10-Q quarterly filing preparation
- ASC 606 revenue recognition analysis
- ASU adoption memos and SEC reporting support
- Audit coordination and disclosure drafting
Valuation context
Arcadia Biosciences engaged Rivers & Moorehead for independent valuation support under the standard(s) listed above. The engagement provides valuation analyses, supporting models, and written deliverables intended to assist the company and its external auditors with financial reporting under U.S. GAAP.
Valuation scope
- ASC 820 fair value measurement of designated financial-reporting items, including selection of valuation technique (market, income, cost), development of unobservable inputs, and classification within the Level 1 / Level 2 / Level 3 fair value hierarchy.
- ASC 805 purchase price allocation – identification and fair value measurement of acquired identifiable intangible assets (e.g., customer relationships, trade names, developed technology, non-compete agreements), tangible assets, and assumed liabilities, with residual goodwill calculation and opening balance sheet support.